propranolol has been researched along with Postural Orthostatic Tachycardia Syndrome in 12 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Postural Orthostatic Tachycardia Syndrome: A syndrome of ORTHOSTATIC INTOLERANCE combined with excessive upright TACHYCARDIA, and usually without associated ORTHOSTATIC HYPOTENSION. All variants have in common an excessively reduced venous return to the heart (central HYPOVOLEMIA) while upright.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Low-dose oral propranolol significantly attenuated tachycardia and improved symptoms in POTS." | 9.14 | Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. ( Biaggioni, I; Black, BK; Dupont, WD; Paranjape, SY; Raj, SR; Ramirez, M; Robertson, D, 2009) |
| "To evaluate the short-term effectiveness of reduced-osmolarity oral rehydration salt formulation (ORS) and propranolol in children diagnosed with postural orthostatic tachycardia syndrome (POTS) in head-up tilt testing (HUTT)." | 5.34 | Short-term efficacy of ORS formulation and propranolol regimen in children with POTS. ( Coban, S; Erenberk, U; Ergor, SN; Karaarslan, U; Karadeniz, C; Oner, T; Temur, HO; Yozgat, CY; Yozgat, Y, 2020) |
| "Low-dose oral propranolol significantly attenuated tachycardia and improved symptoms in POTS." | 5.14 | Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. ( Biaggioni, I; Black, BK; Dupont, WD; Paranjape, SY; Raj, SR; Ramirez, M; Robertson, D, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, HY | 1 |
| Essig, F | 1 |
| Wickel, J | 1 |
| Besteher, B | 1 |
| Neugebauer, H | 1 |
| Haeusler, KG | 1 |
| Müllges, W | 1 |
| Schwab, M | 1 |
| Goodman, B | 1 |
| Jariwala, S | 1 |
| Yozgat, Y | 1 |
| Temur, HO | 1 |
| Coban, S | 1 |
| Oner, T | 1 |
| Karaarslan, U | 1 |
| Yozgat, CY | 1 |
| Karadeniz, C | 1 |
| Ergor, SN | 1 |
| Erenberk, U | 1 |
| Smith, EC | 1 |
| Diedrich, A | 2 |
| Raj, SR | 3 |
| Gamboa, A | 2 |
| Shibao, CA | 1 |
| Black, BK | 2 |
| Peltier, A | 1 |
| Paranjape, SY | 3 |
| Biaggioni, I | 3 |
| Okamoto, LE | 2 |
| Kim, P | 1 |
| During, E | 1 |
| Miglis, M | 1 |
| Moon, J | 1 |
| Kim, DY | 1 |
| Lee, WJ | 1 |
| Lee, HS | 1 |
| Lim, JA | 1 |
| Kim, TJ | 1 |
| Jun, JS | 1 |
| Park, B | 1 |
| Byun, JI | 1 |
| Sunwoo, JS | 1 |
| Lee, ST | 1 |
| Jung, KH | 1 |
| Park, KI | 1 |
| Jung, KY | 1 |
| Kim, M | 1 |
| Lee, SK | 1 |
| Chu, K | 1 |
| Casas, G | 1 |
| Rivas-Gándara, N | 1 |
| Francisco-Pascual, J | 1 |
| Moya-Mitjans, À | 1 |
| García-Dorado, D | 1 |
| Arnold, AC | 1 |
| Noyes, AM | 1 |
| Kluger, J | 1 |
| Ramirez, M | 1 |
| Dupont, WD | 1 |
| Robertson, D | 1 |
| Fu, Q | 1 |
| Vangundy, TB | 1 |
| Shibata, S | 1 |
| Auchus, RJ | 1 |
| Williams, GH | 1 |
| Levine, BD | 1 |
| Kimpinski, K | 1 |
| Figueroa, JJ | 1 |
| Singer, W | 1 |
| Sletten, DM | 1 |
| Iodice, V | 1 |
| Sandroni, P | 1 |
| Fischer, PR | 1 |
| Opfer-Gehrking, TL | 1 |
| Gehrking, JA | 1 |
| Low, PA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment of Orthostatic Intolerance[NCT00262470] | Phase 1/Phase 2 | 150 participants (Anticipated) | Interventional | 1997-04-30 | Active, not recruiting | ||
| Comparison of Effect of Propranolol, Bisoprolol, Pyridosgitmine in Postural Orthostatic Tachycardia Syndrome (POTS) and Prognosis After Medical Treatment[NCT02171988] | Phase 4 | 150 participants (Actual) | Interventional | 2014-03-31 | Completed | ||
| Post-Acute Sequelae of Coronavirus-19 (COVID-19) With DysPnEA on ExertIon And Associated TaChycardia TrEatment Study[NCT05096884] | Early Phase 1 | 20 participants (Anticipated) | Interventional | 2022-03-23 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 trials available for propranolol and Postural Orthostatic Tachycardia Syndrome
| Article | Year |
|---|---|
Short-term efficacy of ORS formulation and propranolol regimen in children with POTS.
Topics: Adolescent; Adrenergic beta-Antagonists; Child; Combined Modality Therapy; Electrolytes; Female; Flu | 2020 |
Splanchnic Venous Compression Enhances the Effects of ß-Blockade in the Treatment of Postural Tachycardia Syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Compression Bandages; Cross-Over Studies; Female | 2020 |
Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Bisoprolol; Female; Foll | 2018 |
Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Exercise Test; Female; Humans; Oxygen Consumption; P | 2013 |
Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cross-Over Studies; Dose-R | 2009 |
Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cross-Over Studies; Dose-R | 2009 |
Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cross-Over Studies; Dose-R | 2009 |
Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cross-Over Studies; Dose-R | 2009 |
Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cross-Over Studies; Dose-R | 2009 |
Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cross-Over Studies; Dose-R | 2009 |
Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cross-Over Studies; Dose-R | 2009 |
Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cross-Over Studies; Dose-R | 2009 |
Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cross-Over Studies; Dose-R | 2009 |
Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Pressure; Double-Blind Method; Exercise Thera | 2011 |
6 other studies available for propranolol and Postural Orthostatic Tachycardia Syndrome
| Article | Year |
|---|---|
Acute onset and severe manifestation of postural orthostatic tachycardia syndrome - Two cases.
Topics: Anti-Arrhythmia Agents; Cerebrovascular Circulation; Dizziness; Female; Heart Rate; Humans; Postural | 2020 |
Dupilumab as a novel therapy to treat adrenergic urticaria.
Topics: Adolescent; Adrenergic beta-Antagonists; Antibodies, Monoclonal, Humanized; Exanthema; Histamine Ant | 2021 |
A Case of Narcolepsy Type 2 and Postural Tachycardia Syndrome Secondary to Lesions of the Thalamus and Amygdala.
Topics: Adolescent; Adrenergic beta-Antagonists; Amphetamine; Amygdala; Central Nervous System Stimulants; D | 2018 |
Postural Orthostatic Tachycardia Syndrome and Vasospastic Angina: Therapeutic Approach to a Previously Unreported Association.
Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Anti-Inflammatory Agents; Cardiovascular Agen | 2019 |
A tale of two syndromes: Lyme disease preceding postural orthostatic tachycardia syndrome.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Diet, Gluten-Free; Female; Fluid Therapy; Humans; Lyme Di | 2015 |
A prospective, 1-year follow-up study of postural tachycardia syndrome.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Adult; Anti-Inflammato | 2012 |